Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BiActive
- Development stage
- Unknown
- Lead developer
- Astrapharm
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
BiActive is a line of dietary supplements developed and manufactured by the Ukrainian pharmaceutical company Astrapharm. The product is primarily designed to restore and maintain a healthy balance of intestinal microflora, particularly in cases of dysbiosis resulting from antibiotic therapy, dietary changes, or digestive disturbances. The standard **BiActive** formulation is a synbiotic, combining probiotic microorganisms (such as *Lactobacillus acidophilus* and *Bifidobacterium animalis* subsp. *lactis*) with the prebiotic inulin, which serves as a nutrient source for beneficial bacteria. The **BiActive Detox** variant incorporates silicon dioxide, an enteral sorbent that facilitates the adsorption and elimination of endogenous and exogenous toxins, allergens, and metabolic byproducts from the gastrointestinal tract. Both versions are administered orally as a powder from sachets.
- Brand names
- BiActiveBiActive Detox
Beyond the preview
Go deeper on BiActive.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BiActive.